{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0121-1018",
      "generic_name": "buprenorphine hydrochloride and naloxone hydrochloride",
      "labeler_name": "PAI Holdings, LLC dba PAI Pharma",
      "dea_schedule": "CIII",
      "brand_name": "Buprenorphine and Naloxone",
      "active_ingredients": [
        {
          "name": "BUPRENORPHINE HYDROCHLORIDE",
          "strength": "2 mg/1"
        },
        {
          "name": "NALOXONE HYDROCHLORIDE",
          "strength": ".5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0121-1018-30",
          "description": "30 TABLET in 1 BOTTLE, PLASTIC (0121-1018-30)",
          "marketing_start_date": "20230905",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "PAI Holdings, LLC dba PAI Pharma"
        ],
        "rxcui": [
          "351266",
          "351267"
        ],
        "spl_set_id": [
          "d5b011ef-f1be-47f2-8f8b-07553f36193c"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0301211018304",
          "0301212036307"
        ],
        "unii": [
          "56W8MW3EN1",
          "F850569PQR"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "5c5bd328-aba7-4c89-9380-b7100d9bcf17",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBLINGUAL"
      ],
      "marketing_start_date": "20230905",
      "product_id": "0121-1018_5c5bd328-aba7-4c89-9380-b7100d9bcf17",
      "application_number": "ANDA204431",
      "brand_name_base": "Buprenorphine and Naloxone",
      "pharm_class": [
        "Opioid Antagonist [EPC]",
        "Opioid Antagonists [MoA]",
        "Partial Opioid Agonist [EPC]",
        "Partial Opioid Agonists [MoA]"
      ]
    }
  ]
}